Updates are available Correction dated 2024-10-01
Click to view Correction: https://doi.org/10.1245/s10434-024-16315-4
-
Authors
Dominici, Laura S.
Laws, Alison
Lagendijk, Mirelle
Grossmith, Samantha
Hughes, Melissa
Lin, Nancy
Mittendorf, Elizabeth A.
King, Tari A.
-
Funding
Funding for this research was provided by:
Dana-Farber/Harvard Cancer Center (P50CA168504)
Rob and Karen Hale Distinguished Chair in Surgical Oncology
Fashion Footwear Association of New York
- License Information
-
More Information
Article History
Received: 22 April 2024
Accepted: 8 July 2024
First Online: 24 July 2024
Change Date: 1 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-024-16315-4
Disclosures
: This study was presented in part as an oral abstract at the 2022 Society of Surgical Oncology (SSO) International Conference on Surgical Cancer Care, Dallas, TX. E.A.M. reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech, Merck, and Moderna; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp and Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. E.A.M. also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. T.A.K. reports speaker honoraria for Exact Sciences and compensated service on the FES Steering Committee and GE Healthcare, and compensated service as faculty for PrecisCa cancer information service.
